Suture-mediated patent foramen ovale closure with the NobleStitch EL system: a systematic review and single-arm meta-analysis
European Heart Journal - Valvular and Structural Heart Disease

Abstract
Transcatheter patent foramen ovale (PFO) closure is usually performed with device-based occluders, which leave a permanent implant and carry a risk of new-onset atrial fibrillation (AF). The NobleStitch EL system is a deviceless suture-mediated alternative, but no quantitative synthesis of its outcomes exists.
To estimate pooled rates of significant residual shunt, post-procedural AF, and recurrent ischaemic events after NobleStitch EL PFO closure.
We systematically searched five databases through May 2026 for observational studies of NobleStitch EL PFO closure. A single-arm random-effects meta-analysis of proportions (Freeman–Tukey transformation, DerSimonian–Laird model) was performed, with quality appraised using the Joanna Briggs Institute checklist. Pre-specified sensitivity analyses included leave-one-out, imaging-modality subgroups, targeted exclusions, and a logit–restricted maximum-likelihood model. The review was registered with PROSPERO (CRD420261406437).
Eight studies (1082 patients) were included. Over a patient-weighted median imaging follow-up of 1.0 year (IQR, .9–1.0), pooled significant residual-shunt rate was 16.1% (95% confidence interval [CI]: 11.6%–21.2%;
Suture-mediated PFO closure with the NobleStitch EL system was associated with a significant residual-shunt rate of ∼16%–18% and very low rates of post-procedural AF and recurrent ischaemic events. These observational, hypothesis-generating findings support the NobleStitch EL system as a deviceless alternative in selected patients.
Contributors

Giulio Falasconi
Author

Gregory A Sgueglia
Author

James A Thompson
Author

Paolo Costa
Author

Bryan W Kluck
Author

Tommasa Siragusa
Author

Cosmo Godino
Author

Achille Gaspardone
Author
You may be interested in








